文献速递神经肿瘤

术中开放脑室对恶性胶质瘤BCNU wafer植入后并发症发生无影响

Intraoperative Ventricular Opening has No Effect on Complication Development Following BCNU Wafer Implantation for Malignant Glioma.
PubMed 文献 · World Neurosurg · 2022-12-24

该单中心回顾性研究纳入2013年3月至2021年8月间66例恶性胶质瘤切除后植入BCNU wafer的连续患者,按术中是否开放脑室分为两组,每组33例。开放脑室组术后不良事件发生7/33例(21.2%),未开放组10/33例(30.3%),两组间无差异(P=0.574)。作者认为术中开放脑室可能不影响术后不良事件的发生。

要点

  • 开放脑室组术后不良事件7/33例(21.2%),未开放组10/33例(30.3%),两组无差异(P=0.574)。
  • 开放与未开放脑室组中位生存时间相似。
  • 作者认为若发生脑室开放,精确闭合脑室后植入BCNU wafer可安全进行。

核心结论

  • 本研究表明,恶性胶质瘤切除联合BCNU wafer植入术中开放脑室可能不影响术后不良事件的发生。
  • 作者认为若术中发生脑室开放,精确闭合脑室后BCNU wafer植入可安全进行。

研究设计与样本

  • 单中心回顾性研究,纳入2013年3月至2021年8月间66例恶性胶质瘤切除后植入BCNU wafer的连续患者。
  • 按术中是否开放脑室分为2组,开放脑室组33例,未开放脑室组33例。
  • 58例为胶质母细胞瘤,8例为间变性星形细胞瘤或少突胶质细胞瘤;48例接受初始治疗,18例接受复发手术。

主要发现

  • 开放脑室组术后不良事件发生7/33例(21.2%),未开放脑室组10/33例(30.3%),两组间无差异(P=0.574)。
  • 初始治疗组中位生存时间28个月,复发治疗组11.5个月。
  • 开放脑室组与未开放脑室组中位生存时间相似。

关键数值与推荐

  • 不良事件定义为:感染、脑积水、皮下积液、慢性硬膜下血肿、术后1个月内早期癫痫、切除腔周围症状性水肿、囊肿形成及术后出血。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the safety profile of bis-chloroethyl-nitrosourea (BCNU) wafer implantation after malignant glioma resection with or without ventricular opening (VO). METHODS: This single-center retrospective study included 66 consecutive patients with BCNU wafer implantation after malignant glioma resection between March 2013 and August 2021. The patients were categorized into 2 groups based on whether VO occurred during the malignant glioma resection. Fifty-eight patients had glioblastoma, and 8 had anaplastic astrocytoma or oligodendroglioma. Forty-eight patients underwent an initial treatment, and 18 underwent recurrent surgeries. Infection, hydrocephalus, subcutaneous fluid collection, chronic subdural hematoma, early seizure after surgery within 1 month, symptomatic edema surrounding the resected cavity, cyst formation, and postoperative hemorrhage were defined as adverse events (AEs). RESULTS: Thirty-three patients underwent resection with VO, and 33 without. The median survival time was 28 months in the initial treatment group and 11.5 months in the recurrent treatment group. The with and without VO groups had similar median survival times. Postoperative AEs occurred in 7/33 patients (21.2%) with VO and 10/33 (30.3%) without VO, with no difference between them (P = 0.574). CONCLUSIONS: This study showed that VO during surgery with BCNU wafer implantation might not influence the occurrence of postoperative AEs. If VO happens, BCNU wafer implantation can be performed safely with accurate closing of the ventricle.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Matsuda R, Maeoka R, Tokuda N, et al. Intraoperative Ventricular Opening has No Effect on Complication Development Following BCNU Wafer Implantation for Malignant Glioma. World Neurosurg. 2022. PMID: 36574919. doi:10.1016/j.wneu.2022.12.090

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。